More biotech companies have been founded after stagnation in the last 2 years. However, 2016 has been slow in private Biotech funding. Danish LS Trend Analysis 2016 Looking for your next Biotech or Medtech partner? Use Biotechgate to identify new leads, licensing opportunities and management details. Get started now Learn more
New database tracks Swedish Life Science expertise
The database Swedishlifesciences.com is a new competence-matching option for entrepreneurs and researchers developing an idea into a product or service for the health care system. Free and open, this online shortcut identifies the expertise needed for a successful innovation process. Too many start-ups and entrepreneurs find it hard to team up with the right expertise … Continue reading New database tracks Swedish Life Science expertise
German Life Sciences Trend Analysis 2016
2015 was a quiet year in terms of the emergence of new private German biotech companies but in terms of financing, the 12 months remained steady. That being said it was not enough to match the high of the latter half of 2014, where USD 247.5m was raised. Read the full report below. German LS … Continue reading German Life Sciences Trend Analysis 2016
Search different phases of product development on Biotechgate
A powerful feature of the Biotechgate database is the ability to quickly find products at any stage of development. Whether you’re searching for an early stage product in Oncology or a product that is now on the market, you can identify your target in just a couple of clicks. Simply go to the product section … Continue reading Search different phases of product development on Biotechgate
Canadian Life Sciences Trend Analysis 2016
The amount of private Canadian biotech companies founded in 2015 was the lowest in at least 10 years, with just two new businesses entering the field. However private Biotech funding has enjoyed a small increase in total investment in H1 of 2016 when compared to the final months of last year. Download the full trend … Continue reading Canadian Life Sciences Trend Analysis 2016
Life Sciences in Europe Report – Smart Site Selection
Zurich / Singapore, June 2016 – Venture Valuation together with KPMG and its new partner EuropaBio has released its third Report on “Site Selection for Life Sciences companies in Europe”. The report now also added additional countries including Denmark, Finland, Italy, Spain and Sweden. The report looks at the strength of Biotechnology, Medical Technology and … Continue reading Life Sciences in Europe Report – Smart Site Selection
Lead generation made simple
We have all been there, whether it’s looking for partners, potential clients or investors; spending far too much time mining the internet for key information and contacts. As you probably already know time is money and this time should be spent engaging with prospects rather than searching for them. The Biotechgate database enables you to … Continue reading Lead generation made simple
Biotechgate launches agreement with AusBiotech to initiate the AusBiotech Australian Life Science Innovation Directory
Zurich May 2016: AusBiotech, in an agreement with Biotechgate, launches the AusBiotech Australian Life Science Innovation Directory, a fully searchable database, offering vital information on the biotechnology and life science industry in Australia. The stand-alone platform will be a welcome resource for the sector in Australia and also sees the Australian Directory join the 38,000-strong … Continue reading Biotechgate launches agreement with AusBiotech to initiate the AusBiotech Australian Life Science Innovation Directory
Swiss Life Sciences Trend Analysis 2016
Our latest trend analysis of the Swiss biotechnology and life sciences sector shows that despite a slow start to the year, investment in the area rose substantially in the second half of 2015. However the decline in the amount of new biotech companies being founded has continued. In fact last year had the lowest number of … Continue reading Swiss Life Sciences Trend Analysis 2016
The Antibiotics Resistance Challenge: Find Out-Licensing Opportunities and More on Biotechgate
Antibiotic resistance has become a significant problem in the global healthcare market. Over-prescribing and misuse, along with the lack of new drug development, means that both governments and the life science industry as a whole have begun to take steps to partner with or fund those companies researching infectious diseases; this is especially true for … Continue reading The Antibiotics Resistance Challenge: Find Out-Licensing Opportunities and More on Biotechgate